| Moldovan, Karen | AARP | Supporting | 2023-2024 |
| Colorado Legislative Strategies | AMGEN | Monitoring | 2023-2024 |
| TRAYLOR, KATHLEEN K. | AMGEN | Monitoring | 2023-2024 |
| Forbes Tate Partners | Alexion Pharmaceuticals, Inc. | Monitoring | 2023-2024 |
| Rodriguez, Luis Armando III | Alexion Pharmaceuticals, Inc. | Monitoring | 2023-2024 |
| Warren, Brian | Biotechnology Innovation Organization | Monitoring | 2023-2024 |
| Swan, Sarah Ehrlich | Bristol Myers Squibb | Monitoring | 2023-2024 |
| Brownstein Hyatt Farber Schreck, LLP | Bristol-Myers Squibb | Monitoring | 2023-2024 |
| Headwaters Strategies | Centennial State Prosperity | Supporting | 2023-2024 |
| Stern, Ellen Steiner | Children's Hospital Colorado | Supporting | 2023-2024 |
| Colorado Legislative Strategies | Colorado BioScience Association | Monitoring | 2023-2024 |
| Pray, Bethany Suzanne | Colorado Center on Law & Policy | Supporting | 2023-2024 |
| Frontline Public Affairs (Miles Consulting, Inc.) | Colorado Center on Law and Policy | Supporting | 2023-2024 |
| Miles Consulting, Inc. dba Frontline Public Affairs | Colorado Center on Law and Policy | Supporting | 2023-2024 |
| Adam, Fox Bennett | Colorado Consumer Health Initiative | Supporting | 2023-2024 |
| Cruz, Isabel Ariel | Colorado Consumer Health Initiative | Supporting | 2023-2024 |
| Stonner, Hope Alina | Colorado Consumer Health Initiative | Supporting | 2023-2024 |
| BRANDEBERRY MCKENNA PUBLIC AFFAIRS | Colorado Hospital Association | Monitoring | 2023-2024 |
| Ewing, Joshua | Colorado Hospital Association | Monitoring | 2023-2024 |
| Frazier, Bridget | Colorado Hospital Association | Monitoring | 2023-2024 |
| Attiya, Amanda | Cystic Fibrosis Foundation | Supporting | 2023-2024 |
| Groves, Shannon E | Kaiser Foundation Health Plan | Monitoring | 2023-2024 |
| Howes Wolf | Merck Sharpe & Dohme Corporation | Monitoring | 2023-2024 |
| Viscarra, Lindsey | National Organization for Rare Disorders | Supporting | 2023-2024 |
| Mendez, Barkis and Associates | RxPlus Pharmacies | Monitoring | 2023-2024 |
| Aponte Public Affairs, Inc. | Vertex Pharmaceuticals Inc. | Supporting | 2023-2024 |
| Aponte Public Affairs, Inc. | Vertex Pharmceuticals Inc. | Supporting | 2023-2024 |